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1  | INTRODUC TION
Disrupted mitochondrial dynamics is one of the hallmarks of aging 
(Lopez-Otin, Blasco, Partridge, Serrano, & Kroemer, 2013). Altered 
mitochondrial morphology and content in skeletal muscle of hu-
mans and rodents are one of the pathways consistently associated 
with age-related loss of muscle mass and function (Bratic & Larsson, 
2013; Short et al., 2005), with up to a 30% loss of mitochondrial con-
tent reported in fast twitch muscles and an accumulation of dysfunc-
tional mitochondria (Chabi et al., 2008). Moreover, accumulation of 
damaged or dysfunctional mitochondria increases the oxidation of 
contractile proteins in muscle, associated with disrupted balance 
between anabolic and catabolic processes and ultimately sarcope-
nia (Carnio et al., 2014; O'Leary, Vainshtein, Iqbal, Ostojic, & Hood, 
2013).
Mitochondria are dynamic organelles that exist in a highly in-
terconnected network and are continually undergoing fusion and 
fission (for review, see Archer, 2013). These processes are tightly 
regulated and necessary to maintain a healthy mitochondrial pop-
ulation by removing and preventing the accumulation of damaged 
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Abstract
One of the key mechanisms underlying skeletal muscle functional deterioration 
during aging is disrupted mitochondrial dynamics. Regulation of mitochondrial dy-
namics is essential to maintain a healthy mitochondrial population and prevent the 
accumulation of damaged mitochondria; however, the regulatory mechanisms are 
poorly	understood.	We	demonstrated	 loss	of	mitochondrial	content	and	disrupted	
mitochondrial dynamics in muscle during aging concomitant with dysregulation of 
miR-181a target interactions. Using functional approaches and mito-QC assay, we 
have established that miR-181a is an endogenous regulator of mitochondrial dy-
namics	 through	 concerted	 regulation	 of	 Park2,	 p62/SQSTM1,	 and	 DJ-1	 in	 vitro.	
Downregulation of miR-181a with age was associated with an accumulation of au-
tophagy-related proteins and abnormal mitochondria. Restoring miR-181a levels in 
old	mice	prevented	accumulation	of	p62,	DJ-1,	and	PARK2,	and	improved	mitochon-
drial quality and muscle function. These results provide physiological evidence for 
the potential of microRNA-based interventions for age-related muscle atrophy and of 
wider significance for diseases with disrupted mitochondrial dynamics.
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mitochondria. The regulation of mitochondrial remodeling and as-
sociated bioenergetic changes, particularly in skeletal muscle, is key 
for the correct adaptation and response to exercise that results in 
an increased mitochondrial content with improved fatty acid oxi-
dation and glucose homeostasis (Mansueto et al., 2017). Moreover, 
the adaptive cellular response of skeletal muscle to exercise requires 
the autophagic degradation of cellular components, allowing the 
muscle fiber to rebuild and respond to repetitive bouts of exercise 
(Vainshtein, Grumati, Sandri, & Bonaldo, 2014). Interruption of mi-
tochondrial dynamics can result in mitochondrial swelling, loss of 
cristae, destruction of the inner membrane, and impaired respira-
tion (Bratic & Larsson, 2013). A decrease in the expression of reg-
ulators of mitochondrial fusion (Mfn1, Mfn2, and Opa1) and fission 
(Drp1) has been reported in sedentary old individuals, but in senior 
sportsmen that have maintained an active lifestyle their expression 
levels are comparable to younger individuals (Tezze et al., 2017). The 
integration of mitochondrial biogenesis and selective degradation 
via mitophagy is essential for the preservation of healthy muscle, 
and disruption of this balance can result in alterations in muscle bio-
energetics and loss of muscle mass and function (Hood, Memme, 
Oliveira, & Triolo, 2019). Mitophagy is regulated at numerous levels, 
and a number of distinct mitophagic pathways have been elucidated 
such as ubiquitin-mediated mitophagy including the Pink/Parkin 
pathway and ubiquitin independent pathways via mitophagy recep-
tors on the outer mitochondrial membrane (e.g., BNIP3), however, 
the exact regulatory mechanisms remain to be fully understood (for 
reviews, see Montava-Garriga & Ganley, 2019; Palikaras, Lionaki, & 
Tavernarakis, 2018).
microRNAs (miRs) are small 19–25 nt long noncoding RNAs that 
regulate gene expression post-transcriptionally through binding to 
complementary	target	sites	within	mRNAs,	usually	3′UTRs,	 lead-
ing to mRNA degradation and/or inhibition of mRNA translation 
(Bethune,	 Artus-Revel,	 &	 Filipowicz,	 2012).	 miRs	 target	multiple	
genes and are considered a robust mechanism of controlling cel-
lular and tissue homeostasis. The role of miRs in the regulation of 
key cellular mechanisms has become increasingly recognized, in-
cluding skeletal muscle homeostasis, development, regeneration, 
and	 atrophy	 (Cheung	 et	 al.,	 2012;	Goljanek-Whysall	 et	 al.,	 2011;	
Soares et al., 2014). The expression of a number of specific miRs 
changes in skeletal muscle during exercise and aging (Kim et al., 
2014; Nielsen et al., 2010). Although limited, functional studies 
have demonstrated that miRs play a key role in regulating the ex-
pression of genes and pathways altered during exercise and/or 
aging, contributing to alterations in skeletal muscle mass (Li, Chan, 
Yu,	&	Zhou,	2017;	Silva,	Bye,	el	Azzouzi,	&	Wisløff,	2017;	Soares	
et al., 2014).
In this study, we have demonstrated that age-related disruption 
of mitochondrial dynamics in skeletal muscle can be improved by 
restoring the expression of miR-181a-5p (miR-181a). Quantitative 
proteomic data revealed a reduced mitochondrial protein content 
with age, concomitant with the upregulation of mitophagy-associ-
ated proteins. Ultrastructural analysis of mitochondria revealed ab-
normal, large mitochondria in muscle during aging despite increased 
expression of autophagy-, and in particular mitophagy-associated 
proteins. Parallel analyses of upstream regulators of mitochondrial 
dynamics identified miR-181a as targeting key autophagy- and mi-
tochondrial dynamics-associated genes. In vitro experiments con-
firmed miR-181a targets p62 and Park2, and demonstrated that 
miR-181a regulates mitophagic flux. Restoration of miR-181a con-
tent in muscle of old mice in vivo prevented accumulation of p62, 
PARK2,	 and	DJ-1	and	preserved	mitochondrial	 content,	ultimately	
resulting in increased myofiber size and muscle force. Together, our 
data indicate that miR-181a is a potent regulator of muscle mito-
chondrial dynamics in vitro and in vivo, providing potential thera-
peutic avenues for age-related muscle atrophy.
2  | RESULTS
2.1 | Quantitative proteomics reveals decrease in 
mitochondrial content with age
To characterize changes in the intracellular muscle environment 
during aging and associated adaptive response of muscle to con-
tractions, global label-free analysis was used to quantify the overall 
changes in the proteome of skeletal muscle from quiescent tibialis 
anterior (TA) or TA subjected to 15 min of isometric contractions 
(mimicking acute exercise) from adult and old mice. Significantly 
changed	proteins	(fold	change	>2	and	−10logP > 20) between qui-
escent or contracted muscle of adult or old mice demonstrate clear 
differences	 in	 the	 proteomic	 content	 of	 TA	 muscle	 (Figure	 1a).	
Despite detected changes in the abundance of some proteins be-
tween contracted muscle of adult and old mice, the major signif-
icant proteomic changes detected were as a result of aging. The 
most significantly changed pathways in muscle during aging were 
downregulation of mitochondrial proteins and upregulation of con-
tractile	 apparatus	 proteins	with	 age	 (Figure	 1b,c).	 This	 is	 consist-
ent with previously reported data showing mitochondrial content 
decrease in muscle during aging (Chabi et al., 2008; Hepple, 2014; 
Smith,	Soriano-Arroquia,	Goljanek-Whysall,	Jackson,	&	McDonagh,	
2018).
2.2 | Autophagy regulatory and effector 
proteins are more abundant in skeletal muscle from 
old mice
To further investigate the mechanisms leading to decreased mito-
chondrial content during aging, we analyzed the expression of known 
regulators	 of	 autophagy	 and	 mitochondrial	 dynamics	 by	Western	
blotting and qPCR. General regulators of the autophagic machinery: 
Sirtuin	1	(SIRT-1)	and	Forkhead	box	protein	O3	(FOXO3),	as	well	as	
effector mitophagy proteins, such as PTEN-induced putative kinase 
1	(PINK1),	Parkin	(PARK2),	Protein	DJ-1	(PARK7),	and	the	autophagic	
adaptor protein p62 (Sequestosome 1, Sqstm1), were upregulated in 
muscle	during	aging	(Figure	2a,b).	We	also	observed	downregulation	
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of the expression of Pgc1α	with	age	(Figure	S1).	Despite	upregulation	
of autophagy-associated proteins, swollen and abnormal mitochon-
dria were detected by EM in muscle of old mice, suggesting defec-
tive	mitochondrial	dynamics	 (Figure	2c).	This	 suggests	 impaired	or	
dysfunctional autophagic response and mitochondrial biogenesis in 
skeletal muscle from old compared to adult mice, and an increase in 
p62 levels can be associated with an inhibition of autophagy as it is 
degraded	in	cells	with	normal	autophagic	flux	(Figure	2b).	Analysis	of	
an autophagy marker LC3 revealed more pronounced LC3 punctae 
in	muscle	from	old	mice	(Figure	2d).	The	expression	of	Lc3b	was	up-
regulated, and the levels of CoxIV and Nd-1, indicators of mitochon-
drial content, were downregulated in the muscle of old mice, further 
suggesting dysfunctional autophagic response in aging muscle and in 
the	adaptation	to	exercise	(Figure	2e,f).	Together,	our	data	demon-
strate an accumulation of key regulators of the mitophagic machin-
ery in muscle during aging and defective mitochondrial dynamics 
resulting in accumulation of abnormal mitochondria and loss of mi-
tochondrial content.
2.3 | miR-181a as putative regulator of 
mitochondrial dynamics
To determine upstream regulators of mitochondrial dynamics, we 
analyzed genes associated with mitochondrial biogenesis, fission, 
fusion, and mitophagy for binding sites for microRNAs previously 
shown to be dysregulated in muscle of mice and humans during 
aging (Table S1). miR-181 family was predicted to target multiple 
genes investigated. miR target prediction databases, TargetScan, 
miRnet,	and	miRWalk,	identified	miR-181a-5p	(miR-181a)	as	a	pu-
tative regulator of multiple genes associated with mitochondrial 
dynamics: previously validated targets (highlighted in bold in 
F I G U R E  1   Label-free proteomics of TA muscle from adult and old mice. (a) Heatmap of significantly changed proteins (fold change >2, 
−10logP > 20 equivalent to p-value < .01) between adult (adult: 6 months old, n = 6), adult exercised (adult Ex, n = 5), old (old: 24 months old, 
n = 5), and old exercised (old Ex, n = 4). (b, c) Pathway analysis of quantitative proteomic data reveals a downregulation of proteins involved 
in mitochondrial electron transport chain and an upregulation of proteins involved in muscle contraction during aging
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F I G U R E  2  Autophagy	and	mitochondrial	regulators	have	altered	expression	in	skeletal	muscle	during	aging.	(a)	Western	blot	analyses	
showing changes in the protein levels of autophagy-associated proteins in the TA muscle of adult and old male mice. Levels normalized to 
Ponceau S (protein) are shown in the quantification graphs (arbitrary units). (b) Expression levels of mRNA of autophagy-associated gene 
expression. (c) Representative EM images of mitochondria from TA muscles of adult and old mice; m—mitochondria; arrows indicate swollen 
or mitochondria with cristae in disarray. Scale bar: 0.5 µm. (d, e) Immunostaining (d) and qPCR (e) for LC3 on TA muscle of adult and old 
mice. Arrows indicate myofibers positive for LC3. Scale bars indicate 100 µm. Arrows indicate LC3-positive fibers. (f) qPCR analyses of the 
expression of mitochondrial content markers encoded by the mitochondrial genome. (g) qPCR analyses of miR-181a, miR-181b, mR-181c, 
and miR-181d expression in the TA of adult and old mice. (h) qPCR analysis of miR-181a expression in quiescent TA muscle and following 
contractions	protocol	of	adult	and	old	mice.	Adult—6	months	old;	old—24	months	old	male	C57BL6/J	mice.	Ex—TA	following	isometric	
contraction protocol. qPCR: Expression relative to β2-microglobulin (genes) or Rnu6 (miR) is shown. Representative images are shown. 
n = 3–6. Error bars show SEM. *p < .05 Student's t test
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Figure	3a:	Park2,	Sirt-1,	PTEN,	and	Atg-5,	and	novel	putative	tar-
gets:	p62,	DJ-1,	Mfn1,	Mfn2,	and	Tfam	(Figure	3a).	miR-181a,	and	
not miR-181b, miR-181c, or miR-181d, was downregulated in TA 
of	mice	during	aging	and	exercise	of	adult	mice	only	(Figure	2g,h).	
The elevated expression of mitophagy-associated proteins ob-
served in TA from old mice coupled with a decreased expression 
of miR-181a suggested that miR-181a may act as an important 
regulator of autophagy and mitochondrial dynamics during mus-
cle aging.
2.4 | miR-181a regulates mitochondrial dynamics 
in myoblasts
To investigate whether miR-181a regulates mitochondrial dy-
namics, we used the mitochondrial uncoupler, carbonyl cyanide 
m-chlorophenyl hydrazone (CCCP), and autophagic flux inhibitor 
bafilomycin	 A1	 (BAF)	 in	 a	 C2C12	 myoblast	 model.	 CCCP	 treat-
ment decreased expression levels of miR-181a, while miR-181a 
mimic and antagomiR-181a (AM181a) increased and decreased, 
respectively,	 miR-181a	 levels	 in	 C2C12	 cells	 (Figure	 S2a).	 CCCP	
treatment	resulted	in	formation	of	LC3	punctae,	while	BAF	treat-
ment resulted in the accumulation of LC3 punctae colocalized with 
TOM20	(Figure	3d).	miR-181	overexpression	resulted	in	the	pres-
ence	of	LC3-positive	punctae	in	DMSO-,	CCCP-,	and	BAF-treated	
cells, whereas inhibition of miR-181a resulted in the accumula-
tion of LC3 and TOM20 colocalized punctae in DMSO, CCCP, and 
BAF-treated	 cells	 (Figure	 3d).	 Moreover,	 inhibition	 of	 miR-181a	
resulted in decreased LC3 II/I in myoblasts treated with CCCP 
(Figure	 3b,c).	 This	 suggests	 inhibition	 of	miR-181a	may	 result	 in	
stalled autophagy.
In order to investigate miR-181a-mediated regulation of mi-
tochondrial turnover via mitophagy, we used the mito-QC re-
porter	construct	that	contains	tandem	mCherry-GFP	tag	fused	to	
the mitochondrial targeting sequence of the outer mitochondrial 
membrane	protein,	FIS1	(Allen,	Toth,	James,	&	Ganley,	2013).	The	
mitochondrial network fluoresces red and green under normal 
conditions but during mitophagy, with the delivery of mitochon-
dria	 to	 the	 acidic	 environment	 of	 lysosomes,	 GFP	 fluorescence	
is quenched while mCherry remains stable (Allen et al., 2013; 
McWilliams	et	al.,	2016).	CCCP	treatment	 increased	the	number	
of mitochondria associated with lysosomes in Scr controls which 
returned	to	basal	levels	after	BAF	treatment	(Figure	3e,f).	AM181a	
samples showed reduced levels of mitophagic events after CCCP 
treatment	 (Figure	 3e,f),	 whereas	 miR-181a	 overexpression	 led	
to	 increased	mitophagy	 events	 in	 DMSO	 and	 BAF-treated	 cells	
(Figure	 3e,f).	 miR-181a	 or	 AM181a	 treatment	 had	 no	 effect	 on	
cell viability (cytotoxicity assay), and ATP production was mildly 
increased in myoblasts treated with miR-181a in the presence of 
CCCP	(Figure	S2b).
To investigate the consequences of mitophagy regulation by 
miR-181a on mitochondrial content, we analyzed the expression 
of mitochondrial proteins encoded by the mitochondrial genome: 
Cox I, Nd-1 and encoded by the nuclear genome: Tomm20. The 
expression of all the mitochondrial genes was increased following 
miR-181a overexpression and decreased in response to AM181a 
(Figure	3g).
2.5 | miR-181a regulates the expression of p62, 
Park2, and DJ-1
We	 next	 validated	 miR-181a	 predicted	 autophagy-associated	
targets in an in vitro model of mitochondrial uncoupling. No 
changes in the expression of these proteins were detected fol-
lowing miR-181a overexpression or inhibition in C2C12 myoblasts 
(Figure	 S2c,d),	 possibly	 due	 to	 their	 high	 turnover.	 However,	 in	
DMSO-treated cells, inhibition of miR-181a resulted in increased 
levels of p62 mRNA and accumulation of p62 protein which did not 
colocalize	 with	 COXIV	 mitochondrial	 marker	 (Figure	 4a,b).	 miR-
181a overexpression resulted in the presence of p62-, PARK2-, and 
DJ-1-positive	punctae	colocalized	with	 the	mitochondrial	marker	
COXIV.	 In	CCCP-treated	 cells,	 inhibition	of	miR-181a	 resulted	 in	
accumulation	 of	 p62,	DJ-1,	 and	 Park-2	mRNAs	 and	 protein	with	
reduced	 colocalization	 with	 COXIV.	 miR-181a	 overexpression	
resulted in downregulation of the expression of p62, Park2 and 
DJ-1	 in	 CCCP-treated	 cells	 to	 levels	 comparable	 to	 control	 cells	
(Figure	 4a,b).	 Concomitant	 with	 changes	 in	 autophagy-related	
genes, miR-181a overexpression in C2C12 myoblasts treated with 
CCCP	 resulted	 in	 upregulation	 of	 Tfam	 expression	 (Figure	 4b).	
These results indicate that miR-181a increased mitochondrial 
turnover via mitophagy and potentially concomitant increase in 
mitochondrial biogenesis as indicated by increase of Tfam expres-
sion in C2C12 cells treated with miR-181. This indicates a role for 
miR-181a in maintaining a population of healthy mitochondria 
within the cells.
We	also	analyzed	changes	in	localization	of	BNIP3	and	LAMP1	
with TOM20 in C2C12 cells treated with miR-181a or AM181a 
in	 control-,	 CCCP-,	 or	 BAF-treated	 cells.	 Both	 experiments	
demonstrated that AM181a treatment leads to accumulation 
of BNIP3 or LAMP1 punctae colocalized with TOM20, further 
demonstrating that low levels of miR-181a are associated with 
inhibition	of	mitophagic	flux	(Figure	S3).	However,	no	miR-181a	
binding site could be found in the mRNA sequences of Bnip3 or 
Lamp1.
To investigate whether miR-181 directly binds to its target asso-
ciated	with	autophagy,	we	used	3′UTRs	of	p62	and	Park2,	and	DJ-1	
Exon	6	 cloned	downstream	of	GFP	 reporter	 constructs.	Although	
miR binding sites within exons are very uncommon, we analyzed 
this specific putative binding site due to strong effects of miR-
181a	on	DJ-1	expression	(Figure	4c).	GFP	reporter	constructs	were	
transfected into C2C12 cells in the presence of scrambled (control 
miR	not	predicted	to	bind	to	3′UTRs)	or	miR-181a	mimic.	miR-181a	
treatment	led	to	significant	decrease	in	GFP	fluorescence	from	GFP-
p62	and	GFP-Park2,	but	not	GFP-DJ-1	constructs,	as	compared	to	
scrambled-treated	controls	(Figure	4d).	The	mutations	of	miR-181a	
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binding	sites	within	the	3′UTRs	of	the	investigated	genes	rendered	
all constructs nonresponsive to miR-181a overexpression as com-
pared to scrambled controls. This confirms p62 and Park2 as direct, 
targets	of	miR-181a,	whereas	DJ-1	expression	may	be	regulated	by	
miR-181a	in	an	indirect	manner	(Figure	4c,d).
2.6 | miR-181a regulates expression of p62, DJ-
1, and Parkin in vivo
The expression and localization of miR-181a regulated genes were 
analyzed in the muscle of adult and old mice treated with saline, 
     |  7 of 16GOLJANEK-WHYSALL Et AL.
miR-181a	mimic,	or	AM181a	(Figures	5,	6,	and	S6).	The	muscle	of	
control old mice was characterized by the presence of increased 
p62,	 DJ-1,	 and	 PARK2-positive	 myofibers	 as	 compared	 to	 the	
muscle of control adult mice, confirming disrupted or inhibited 
autophagy	 during	 aging	 (Figure	 5a).	 AM181a	 treatment	 of	 adult	
mice	led	to	increased	number	of	p62-,	DJ-1-,	and	PARK2-positive	
myofibers,	 whereas	 fewer	 p62-,	 DJ-1-,	 and	 PARK2-positive	 my-
ofibers were detected in miR-181a-treated old mice compared 
to	their	 respective	controls	 (Figure	5a).	 Inhibition	of	miR-181a	 in	
muscle	of	adult	mice	led	to	accumulation	of	p62	and	DJ-1	mRNA,	
whereas overexpression of miR-181a in muscle of old mice led 
to	reduced	levels	of	p62,	Park2,	and	DJ-1	mRNA	as	compared	to	
muscle of control old mice to levels observed in muscle of adult 
mice	 (Figure	 5b).	 This	 suggests	 that	 lower	 levels	 of	miR-181a	 in	
muscle are associated with accumulation of its target genes and 
potentially dysfunctional mitophagy, leading to an accumulation 
of	dysfunctional	mitochondria	 (Figure	6g).	To	 further	 investigate	
the role of miR-181a in regulating mitochondria, we analyzed the 
expression of mitochondrial genes (CoxI and Nd-1) in TA muscle of 
adult and old mice. Consistently, in muscle of old mice, miR-181a 
treatment led to increased expression of mitochondrial genes as 
a	marker	 of	mitochondrial	 content	 (Figure	 5c).	 Furthermore,	 we	
investigated changes in the expression of transcription factors 
promoting mitochondrial biogenesis: the master regulator of mi-
tochondrial biogenesis (PGC1α) and the mitochondrial transcrip-
tion factor (Tfam). Consistently in miR-181a-treated muscle, the 
expression of these mitochondrial biogenesis-associated genes 
was	 upregulated	 (Figures	 5c	 and	 S5).	 Together,	 these	 results	 in-
dicate that miR-181a promotes mitochondrial dynamics through 
concomitant activation of mitophagy and mitochondrial biogen-
esis in skeletal muscle from adult and old mice.
2.7 | miR-181a regulates mitochondrial quality, 
myofiber size, and muscle force in vivo
We	next	investigated	the	physiological	effects	of	miR-181a	on	mus-
cle during aging. Changes in miR-181a expression in adult and old 
mice	had	no	significant	effect	on	body	or	muscle	weight	(Figure	S6).	
However, miR-181a inhibition led to a decrease, whereas miR-181a 
overexpression led to an increase in myofiber size from adult and old 
mice,	respectively	(Figure	6a,b).	The	relative	proportion	of	fiber	sizes	
within the population of fibers revealed that miR-181a-treated mice 
had a higher proportion of larger fibers, whereas AM181a treatment 
resulted in a higher population of smaller fibers in muscle from adult 
mice	 (Figure	 6c).	 Moreover,	 a	 higher	 proportion	 of	 LC3-positive	
myofibers was detected in muscle of control old mice and AM181a-
treated adult and old mice, with almost no LC3-positive fibers de-
tected	in	adult	saline	and	miR-181a-treated	mice	(Figure	6e).	These	
results indicate miR-181a-mediated regulation of mitochondrial con-
tent is associated with fiber size.
The relative oxidative potential of muscle as an indication of mi-
tochondrial function was decreased by miR-181a inhibition in the TA 
of adult mice, demonstrated by reduced intensity of succinate de-
hydrogenase	(SDH)	staining	(Figure	6f,g).	miR-181a	treatment	of	old	
mice resulted in a nonsignificant trend for increased SDH intensity 
(Figure	6g).	EM	analysis	of	mitochondrial	populations	revealed	the	
presence of swollen and mitochondria with disordered cristae, with 
some mitochondria expanding longitudinally between myofibrils, 
in muscle of control old and AM181a-treated adult mice. miR-181a 
treatment of old mice led to a lower proportion of structurally ab-
normal mitochondria and decreased the abundance of abnormally 
large	mitochondria	(Figure	6d).
The physiological relevance of manipulating miR-181a expres-
sion was investigated by examining the effects of miR-181a on 
muscle force. Maximum and specific force of the EDL muscle was 
decreased	during	aging	 (Figure	6h).	As	miR-181a	expression	 is	de-
creased in muscle during aging, we treated adult mice with AM181a 
to reduce miR-181a expression. Conversely, old animals were treated 
with miR-181a mimic in an effort to restore miR-181a expression. 
Maximum and specific force was decreased in muscle of adult mice 
treated with AM181a, whereas miR-181a overexpression in muscle 
of	old	mice	 restored	maximum	muscle	 force	 (Figure	6h).	Together,	
these data suggest that a decrease in miR-181a expression results in 
chronic dysregulated mitophagy in muscle during aging associated 
with presence of abnormal mitochondria, loss of mitochondrial con-
tent, and decline of muscle function.
In summary, a decrease in miR-181a expression resulted in in-
creased expression of autophagy-associated genes, a decrease in 
fiber diameter, and specific muscle force in adult mice mimicking 
aging. Conversely, upregulating miR-181a levels in old mice improved 
mitochondrial morphology, increased fiber diameter, and specific 
F I G U R E  3   miR-181a regulates mitochondrial dynamics in vitro. (a) Schematic representation of putative and validated (in bold) miR-
181a	targets	associated	with	mitochondrial	dynamics.	(b,	c)	LC3	I/II	Western	blot	and	quantification	of	LC3II/I	ratio	of	C2C12	myoblasts	
following transfections with scrambled antagomiR, miR-181a mimic, or antagomiR-181 and CCCP treatment. (d) Immunostaining of C2C12 
myoblast transfected with scrambled antagomiR (control), miR-181a mimic, or antagomiR-181a for LC3 and the mitochondrial marker 
TOM20	following	DMSO,	CCCP,	or	BAF	treatments.	Yellow	arrows	indicate	accumulation	of	LC3B	+	TOM20+	punctae,	and	white	arrows	
indicate LC3-positive punctae. Scale bars show 30 µm. Representative images are shown. (e) Assessment of mitophagic flux in C2C12 cells 
treated	with	scrambled	antagomiR	(control),	miR-181a	mimic,	or	antagomiR-181a	in	control	(DMSO)	or	cells	treated	with	CCCP	or	BAF	
using	mito-QC	construct.	Mitochondria	are	labeled	with	mCherry	and	GFP;	upon	mitophagy	induction,	GFP	signal	is	quenched.	Scale	bars	
indicate 10 µm. (f) Quantification of mitophagic events per cell through analysis of colocalization of red punctae only. (g) qPCR analysis of 
mitochondrial	gene	expression	(Cox	I,	Nd-1,	and	Tomm20)	in	C2C12	myoblasts	following	DMSO,	CCCP,	and	BAF	treatments	and	transfected	
with scrambled antagomiR (control), miR-181a mimic, or antagomiR-181a, respectively, expression relative to β2-microglobulin shown. Error 
bars show SEM; *p < .05 Student's t test
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F I G U R E  4  miR-181a	targets	p62	and	Park2	and	DJ-1	in	C2C12	myoblasts.	(a)	Immunostaining	for	CoxIV	(mitochondrial	marker)	and	
mitophagy-associated	genes:	p62,	DJ-1,	and	Park2,	showing	accumulation	of	these	proteins	in	C2C12	myoblasts	following	inhibition	of	
miR-181a function and turnover of mitochondria following overexpression of miR-181a. Arrows indicate regions with protein expression 
and reduced CoxIV expression indicating mitophagy. Representative images are shown. Scale bars indicate 50 µm. (b) qPCR showing the 
effects of miR-181 in C2C12 myoblasts following mitophagy induction on the expression of mitophagy-associated genes, relative to β2-
microglobulin. n = 3–4. Error bars show SEM. *p < .05; unpaired Student's t	test.	(c)	miR-181a	predicted	binding	sites	within	the	3′UTRs	
of	murine	p62	and	Park2	and	within	an	exon	of	murine	DJ-1.	Red—microRNA	seed	sequence;	green—nucleotides	complementary	to	the	
microRNAs	sequence.	(d)	Normalized	GFP	fluorescence	in	myoblasts	following	co-transfection	with	GFP	sensor	construct	containing	wild-
type or mutated miR-181a predicted binding site and miR-181a mimic or scrambled miRNA mimic. n = 3. Error bars show stdev. *p < .05 
Student's t test
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F I G U R E  5  miR-181a	regulates	expression	of	p62,	DJ-1,	and	Parkin	and	affects	mitochondrial	content	markers	in	vivo.	(a)	Representative	
images	of	TAs	immunostained	for	p62,	DJ-1,	and	Park2	following	miR-181a	gain	and	loss	of	function.	Arrows	indicate	positive	fibers.	Scale	
bars indicate 100 µm. n = 3. (b) miR-181a gain and loss of function in TA of adult and old mice leads to changes in the expression of p62, 
DJ-1,	and	Park2	mRNA,	relative	to	β2-microglobulin. (c) miR-181a overexpression increases the expression of mRNA of mitochondrial genes 
(Cox I, Nd-1) and regulator of mitochondrial biogenesis (Tfam) in TA of adult and old mice, relative to β2-microglobulin. Error bars show SEM 
*p < .05 Student's t	test.	Adult—6	months	old;	old—24	months	old	male	C57BL6/J	mice;	Ctrl—saline
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force. These data demonstrate microRNA-mediated fine-tuning of 
one of the key mechanisms associated with aging, mitochondrial 
turnover, and provide proof of principle for the potential use of mi-
croRNA-based therapeutic approaches for aging-associated disor-
ders such as age-related muscle atrophy.
3  | DISCUSSION
In the present study, we have demonstrated decreased mitochon-
drial content and quality associated with dysregulated expression 
of autophagy and mitochondrial dynamics-associated proteins in 
skeletal muscle during aging. Using bioinformatics and reporter 
constructs, we have identified miR-181a as a key regulator of p62 and 
Park2,	 and	 indirectly,	 regulation	 of	 Park7/Protein	DJ-1	 expression	
and localization. Changes in miR-181a levels and the concomitant 
changes in the expression of its targets resulted in altered myofiber 
size, mitochondrial content, and quality and specific muscle force, 
suggesting miR-181a may be one of the key regulatory mechanisms 
underlying age-related muscle atrophy. This is the first report, to our 
knowledge, demonstrating a physiologically relevant mechanism of 
miR-181a-mediated fine-tuning of mitochondrial dynamics on mul-
tiple levels through concerted regulation of expression of several 
autophagy-associated genes in muscle during aging.
Mitochondrial quality has an important impact on the health and 
bioenergetics of healthy skeletal muscle and is tightly regulated by 
F I G U R E  6   miR-181a regulates myofiber size and muscle strength in vivo. (a–c) The effects of miR-181a on myofiber size in adult and old 
mice.	WGA	immunostaining	(a),	quantification	of	minimal	Ferret's	diameter	(b),	and	fiber	distribution	analysis	(c)	of	TA	of	adult	and	old	mice	
following intravenous injection of miR-181a mimic, antagomiR, or saline (control). Scale bars indicate 100 µm; arrows indicate statistically 
significant changes in fiber distribution (chi-square test, p < .05). n = 6; *p < .05 unpaired Student's t test. (d) Representative EM images of 
TA from adult and old mice. Arrows indicate abnormal mitochondria. Scale bars: 0.5 and 0.2 µm. (e) Inhibition of miR-181a expression in vivo 
leads to the presence of more of LC3-positive myofibers (red), n = 3; arrows indicate LC3-positive fibers. (f, g) Histological examination of 
miR-181 effects on mitochondria: SDH staining and quantification (f) of TA of adult and old mice following miR-181 mimic, antagomiR-181, or 
saline injections, respectively. Scale bars indicate 200 µm; n = 3. (h) Muscle maximum and specific force following miR-181a gain and loss of 
function in vivo evaluated in EDL muscles from adult and old mice; error bars indicate SEM; n = 4–6
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mitochondrial biogenesis, fusion, fission, and selective degradation 
of mitochondria. Mitochondrial content decreases with age in skele-
tal muscle; however, the exact mechanisms are not fully understood 
(Hepple,	2014).	 Functional	 autophagy	and	mitophagy	are	 affected	
by aging and have been associated with changes in mitochondrial dy-
namics	(Carnio	et	al.,	2014;	Sebastian	et	al.,	2016).	We	have	detected	
an increase in the expression of the regulators of Pink1/Parkin-
dependent mitophagy during aging and the presence of abnormal 
mitochondria, suggesting this mitophagy pathway is disrupted or 
ineffective, resulting in an accumulation of abnormal mitochondria.
The role of mitophagy and autophagy in skeletal muscle is con-
text-dependent and even small changes in mitochondrial dynamics 
can have detrimental consequences on muscle mass and function 
with an accumulation of abnormal mitochondria (Carnio et al., 2014; 
Drake,	Wilson,	&	Yan,	2016).	Dysregulated	mitophagy	is	associated	
with decreased functional mitochondria in muscle during aging, 
where changes in mitochondrial fusion or fission may lead to the 
presence of abnormally large mitochondria (Mao & Klionsky, 2013). 
In mice, the deletion of the mitochondrial fusion protein, OPA1, 
produced a lethal phenotype, while inducible muscle-specific de-
letion of OPA1 resulted in a disruption of mitochondrial morphol-
ogy, proteasome activation, and muscle atrophy (Tezze et al., 2017). 
Similarly, inducible muscle-specific deletion of the mitochondrial 
fission protein, DRP1, resulted in the formation of functionally ab-
normally large mitochondria, activation of the ER stress response, 
an increase in Ca2+	uptake	and	myofibre	death	(Favaro	et	al.,	2019).	
Interestingly, inducible muscle-specific deletion of both OPA1 and 
DRP1 rescued the lethal phenotype of OPA1 knockout, suggesting 
that in the context of mitochondrial dynamics inhibition of fission 
has precedence over inhibition of fusion (Romanello et al., 2019).
In C. elegans, the age-related decline in mitophagy inhibits both 
the removal of dysfunctional mitochondria and impairs mitochon-
drial biogenesis (Palikaras, Lionaki, & Tavernarakis, 2015). It has 
been proposed that the age-related accumulation of dysfunctional 
mitochondria triggers the activation of SKN-1, the nematode homo-
logue of Nrf2 (Palikaras et al., 2015). Activation of SKN-1 triggered 
a bipartite retrograde signaling pathway coupling the induction of 
mitochondrial biogenesis and mitophagy genes (Palikaras et al., 
2015). It has also been demonstrated that during the myogenic dif-
ferentiation of C2C12 myoblasts, there is an induction of mitoph-
agy with a corresponding increase in mitochondrial biogenesis (Sin 
et al., 2016). As miRs have been shown to fine-tune gene expression, 
they are ideal candidates to control this delicate between removal 
of dysfunctional/damaged mitochondria and mitochondrial biogen-
esis. Several microRNAs, including miR-149, miR-761, and miR-494, 
have been identified that can inhibit or promote mitochondrial bio-
genesis	 (Mohamed,	 Hajira,	 Pardo,	 &	 Boriek,	 2014;	 Xu,	 Zhao,	 Sun,	
Liu, & Zhang, 2015; Yamamoto et al., 2012) for review (Dahlmans, 
Houzelle, Schrauwen, & Hoeks, 2016).
In this study, we identified miR-181a, which has decreased ex-
pression in muscle during aging, as a putative regulator of multiple 
genes associated with the regulation of mitochondrial dynamics. 
miR-181a-mediated regulation of components of autophagy has 
previously been reported in aging, cancer cell lines, and nervous 
system (Cheng et al., 2016; Indrieri et al., 2019; Rippo et al., 2014; 
Soriano-Arroquia, House, Tregilgas, Canty-Laird, & Goljanek-
Whysall,	 2016;	 Tekirdag,	 Korkmaz,	 Ozturk,	 Agami,	 &	 Gozuacik,	
2013). Recently, overexpression of miR-181a/b-1 in chondrocytes 
resulted in improvements in mitochondrial metabolism (Zheng, Liu, 
Tycksen, Nunley, & McAlinden, 2019). Our results indicate miR-181a 
regulates autophagy/mitophagy and effector proteins, providing a 
mechanism of fine-tuning mitochondrial dynamics through parallel 
regulatory	 pathways.	We	 have	 demonstrated	 that	miR-181a	 regu-
lates the expression and localization/function of multiple autopha-
gy-related	genes:	Park2,	p62,	and	Protein	DJ-1/Park7	(Figures	3,	4	
and 5), concomitant with upregulation of mitochondrial biogenesis. 
Mitophagy and mitochondrial biogenesis have been demonstrated 
to be coupled previously (Palikaras et al., 2015; Sin et al., 2016). 
Moreover, restored expression of miR-181a in the muscle of old 
mice prevented accumulation of mitophagy-associated proteins and 
was related with increased mitochondrial content and improved mi-
tochondrial	quality	(Figures	5	and	6).	We	also	observed	a	decrease	in	
the presence of swollen and abnormally large mitochondria in muscle 
of	old	mice	following	miR-181a	overexpression	(Figure	6).	Although	
these changes could be associated with miR-181a predicted target 
genes: Mfn1 and Mfn2, we did not observe consistent regulation 
of	these	genes	by	miR-181a	at	the	mRNA	level	(Figures	S1	and	S5).	
Finally,	we	have	shown	 that	miR-181a	 regulates	myofiber	 size	and	
muscle force: Adult and old mice treated with AM181a or miR-181a 
had significant changes in the expression of genes linked with mito-
chondrial dynamics, mitochondrial quality, and muscle fiber diame-
ter	and	specific	force	of	muscle	(Figure	6).
In summary, we propose that miR-181a regulates skeletal muscle 
homeostasis and muscle metabolism, size, and force, by regulating 
mitochondrial dynamics. miR-181a is downregulated during aging, 
and we propose that concomitant upregulation and accumulation of 
its mitophagy-associated targets paradoxically lead to a stalling or 
inhibition of mitophagy, resulting in the accumulation of damaged 
mitochondria.	We	have	 demonstrated	 that	 fine-tuning	 the	 levels	 of	
autophagy	regulatory	(p62)	and	mitophagy-associated	proteins	(DJ-1,	
Park2) and concomitant changes in the expression of Tfam, by overex-
pressing miR-181a, leads to improved mitochondrial dynamics result-
ing in increased myofiber size and muscle function. In this study, we 
focused on the predicted and confirmed targets of miR-181a many of 
which are associated with the Pink/Parkin mitophagy pathway. It was 
therefore surprising to find that regulation of Parkin, p62, and Protein 
DJ-1	by	miR-181a	overexpression	resulted	in	increased	mitophagy	and	
mitochondrial	biogenesis.	Functional	experiments	in	vitro	and	in	vivo	
demonstrated that decreased miR-181a resulted in the accumulation 
of these target proteins. Low levels of miR-181a in aging muscle were 
associated with accumulation of its target proteins and stalled autoph-
agy. Our data suggest that miR-181a regulates mitochondrial dynamics 
by fine-tuning the Pink/Park pathway and mitochondrial biogenesis, 
potentially in response to stress factors. Moreover, mitophagy is co-
ordinated by a number of conserved cellular pathways, and disrup-
tion of this balance can result in the accumulation of dysfunctional 
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mitochondria and aging (Palikaras et al., 2018). Exercise increases mi-
tochondrial biogenesis in skeletal muscle, and the increased expres-
sion of miR-181a in response to acute exercise (this study and (Safdar, 
Abadi, Akhtar, Hettinga, & Tarnopolsky, 2009) suggests that miR-
181a plays a key role in improving overall mitochondrial health. Our 
results indicate overexpression of miR-181a increases the expression 
of genes required for mitochondrial biogenesis and promotes mito-
phagy either directly or indirectly to restore mitochondrial dynamics. 
There are a number of limitations to the work presented in this man-
uscript.	We	have	determined	from	in	vitro	studies	that	miR-181a	pro-
motes mitophagy,however, mitophagic flux was not directly assessed 
in animal models. Similarly, we used microscopy and the expression 
levels of PGC1α, Tfam, and mitochondrial encoded genes Nd-1 and 
Cox-1 as indirect measures of mitochondrial biogenesis in our models. 
Furthermore,	miR-181a	overexpression	resulted	in	improved	physio-
logical parameters in old mice, but the effects on mitochondrial dy-
namics	 in	 other	 tissues	were	 not	 examined.	We	 also	 only	 analyzed	
male mice in this study and any future work both male and female 
mice should be included.
Despite these limitations, the results of this study demonstrate 
for the first time the microRNA-mediated regulation of mitochon-
drial content in muscle during aging with physiologically relevant 
consequences on myofiber size and strength indicating the potential 
of microRNA-based therapies for age-related muscle atrophy.
4  | E XPERIMENTAL PROCEDURES
4.1 | Mice
The study was performed using male wild-type C57Bl/6 mice (adult: 
6 months old; old—22–24 months old at the beginning of the treat-
ment). Mice were obtained from Charles River (Margate). All mice 
were maintained under specific pathogen-free conditions and fed ad 
libitum a standard chow and maintained under barrier on a 12-hr 
light–dark	 cycle.	 For	 miR-181a-5p	 expression	 manipulation,	 mice	
were injected with 2mg/kg body weight three times during 4-week 
period with miR-181a mimic (GE Healthcare, C-310435-05 conju-
gated	to	cholesterol)	or	custom	antagomiR-181a	(5′-FITC-	mA*mC*
mUmCmAmCmCmGmAmCmAmGmCmGmUmUmGmAmA*mT*m
G*mU*mU—3′Cholesterol;	 m—hydroxymethyl	 modified	 bases;	 *—
phosphorothioate bonds; CH—cholesterol) or saline (control mice). 
Extensor digitorum longus (EDL) muscle force measurements and tis-
sue collection were performed four weeks from the first injection. 
For	tissue	collection,	mice	were	culled	by	cervical	dislocation.	The	
tissues were immediately excised, portions of TA muscles were ei-
ther	directly	frozen	and	stored	at	−80°C	for	qPCR	or	homogenised	
for proteomics and western blotting. A portion of the TA muscle was 
also	embedded	 in	OCT,	 frozen	 is	 isopentane	and	stored	at	−80°C.	
Experiments were performed in accordance with UK Home Office 
guidelines under the UK Animals (Scientific Procedures) Act 1986 
and received ethical approval from the University of Liverpool 
Animal	Welfare	and	Ethical	Review	Body.	For	each	experiment,	n = 3 
(Western	blot	and	qPCR	analyses)	or	n = 6 (adult mice) or n = 4 (old 
mice; force measurements) mice were used.
4.2 | Cell culture
C2C12 myoblasts were maintained in DMEM (Sigma-Aldrich) supple-
mented with 10% fetal bovine serum and 1% penicillin/streptomycin 
(Sigma-Aldrich;	 Goljanek-Whysall	 et	 al.,	 2012).	 For	 cholesterol-linked	
miR-181a mimic, antagomiR-181a, or antagomiR scrambled, 50% con-
fluent C2C2 myoblasts were treated at 100 nM final concentration for 
48 hr previous to treatment with 10 µM CCCP or 100 nM bafilomycin 
A (both Sigma-Aldrich). 16 hr following CCCP treatment or 1 hr after 
bafilomycin A treatment, RNA and protein were isolated from treated 
cells or C2C12 cells were fixed in ice-cold methanol and immunostained 
as	described	below	(muscle	staining).	For	mitophagy	flux	analyses,	mito-
Qc reporter was used as previously described (Allen et al., 2013). In 
brief, mito-QC viral molecules produced in HEK293T cells were used to 
transduce proliferating C2C12 cells. C2C12 cells were simultaneously 
treated with miR-181a mimic or antagomiRs and treated with DMSO 
(control), CCCP, or bafilomycin A and imaged as described above. Images 
were obtained either using a Zeiss fluorescent upright microscope 
(Model Imager M1) couples with AxioCam MRm and AxioVision soft-
ware	4.8	or	with	an	Olympus	Fluoview3000	Laser	confocal	microscope	
and	analysed	using	ImageJ	as	described	previously	(Soriano-Arroquia,	
McCormick,	Molloy,	McArdle,	&	Goljanek-Whysall,	2016).	Cytotoxicity	
and ATP generation were measured using mitochondrial ToxGlo assay 
(G8000) from Promega as per the manufacturer's instructions.
4.3 | In situ muscle function analysis
Force	 measurements	 of	 the	 EDL	 muscles	 were	 performed	 as	 de-
scribed before via peroneal nerve stimulation in adult and old male 
mice (Sakellariou et al., 2016). Briefly, mice were anesthetized using 
ketaset and dormitor. The distal tendon was secured to the lever arm 
of a servomotor (Aurora Scientific). Muscle optimal length (Lo) was 
determined with during a series of 1 Hz stimulation and set at the 
length that generated the maximal force. EDL muscles were elec-
trically stimulated to contract at Lo and optimal stimulation volt-
age (10 V) at 2 min intervals for 300 ms with 0.2 ms pulse width to 
determine maximum isometric tetanic force (Po). The frequency of 
stimulation was increased from 10 to a maximum of 300 Hz in 50 Hz 
increments. Po was identified when the maximum force reached a pla-
teau. Muscle fiber length (Lf) and weight of EDL muscles were meas-
ured ex vivo, and muscle cross-sectional area (CSA) was calculated. 
Specific Po (mN/mm
2) was calculated by dividing Po by total fiber CSA.
4.4 | Muscle staining
TA	 muscles	 were	 cryosectioned	 at	 −20°C	 through	 the	 mid-belly.	
10-μm sections were rinsed with phosphate-buffered saline (PBS) 
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and fixed in ice-cold methanol for 5 min. Sections were incubated in 
blocking solution (1% BSA: Sigma-Aldrich, 10% normal horse serum: 
Thermo	Fisher	Scientific,	UK	0.3	M	glycine:	Sigma-Aldrich,	Dorset	
UK, in 0.1% PBS-Tween: Sigma-Aldrich) for 1 hr at room temperature 
and next incubated with primary antibodies SQSTM1/p62: Abcam, 
UK, ab109012 (anti-rabbit), CoxIV: Cell Signaling, 3E11, Tomm20: 
Abcam, UK, ab56783 (anti-mouse) or ab186734 (anti-rabbit), Lc3b: 
Abcam,	UK,	 ab10912,	DJ-1:	 Abcam,	UK,	 ab76241,	 Parkin:	 Abcam,	
UK, ab15954, Pink1: Abcam, UK, ab23707 (all 1:1,000 dilution in 
blocking	buffer)	diluted	in	5%	horse	serum,	0.01%	Triton	X	in	PBS	for	
2 hr at room temperature. Three PBS washes were performed, and 
sections were next incubated with secondary antibodies diluted in 
5%	horse	serum,	0.01%	Triton	X	in	PBS	(anti-rabbit-Alexa	647,	anti-
mouse—Alexa	 532	or	 488,	 Thermo	Scientific).	 Fluorescein-labeled	
wheat	 germ	 agglutinin	 (WGA,	 Vector	 Laboratories,	 5	 μg/ml) was 
used to identify extracellular matrix. Nuclei were identified using 
4′,6-diamidino-2-phenylindole	 (DAPI,	1	μg/ml, Sigma-Aldrich). SDH 
staining was performed as previously described (Smith et al., 2018). 
Transverse sections from 3 to 4 muscles/treatment group were ex-
amined	by	blinded	observers	to	count	the	minimal	Feret's	diameter.	
ImageJ	software	was	used	to	analyze	individual	muscle	fibers	as	de-
scribed previously (Sakellariou et al., 2016).
4.5 | Proteomics and pathway analysis
TA muscles were immediately dissected and a portion homogenized 
directly in 50 mM ammonium bicarbonate pH 8. Protein lysates were 
prepared by centrifugation at 15,000 g	for	10	min	at	4°C,	and	protein	
concentrations were calculated using Bradford assay (Bio-Rad) with 
BSA as a standard. 100 µg of protein extract was diluted to 160 µl 
with 25 mM ammonium bicarbonate and denatured by the addition 
of	10	µl	of	1%	RapiGest	(Waters)	in	25	mM	ammonium	bicarbonate	
and	incubated	at	80°C	for	10	min	with	shaking.	10	µl	of	a	100	mM	
solution of Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) was 
added to reduce reversibly oxidized Cys residues followed by incu-
bation	 at	 60°C	 for	 10	min.	 Cys	was	 then	 alkylated	 by	 addition	 of	
N-ethylmaleimide and incubated at room temperature for 30 min. 
An aliquot of the samples was used at this point to check procedure 
by SDS-PAGE. Proteolytic digestion was performed by addition of 
Trypsin (Thermo Scientific, Paisley, UK) followed by overnight incu-
bation	at	37°C.	Digestion	was	terminated	and	RapiGest	removed	by	
acidification	(3	µl	of	TFA	and	incubated	at	37°C	for	45	min)	and	cen-
trifugation (15,000 g for 15 min).
4.5.1 | LC–MS/MS and label-free MS quantification
Samples were analyzed using an Ultimate 3000 RSLC nano sys-
tem (Thermo Scientific) coupled to a QExactive mass spectrometer 
(Thermo Scientific). 2µl of sample was diluted in 18 µl buffer (97% 
H2O, 3% MeCN and 0.1% formic acid v/v), and 5 µl corresponding 
to 250 ng of protein was loaded onto the trapping column (PepMap 
100, C18, 75 µm × 20 mm) using partial loop injection for 7 min at 
a	 flow	 rate	of	4	µl/min	with	0.1%	 (v/v)	TFA.	Sample	was	 resolved	
on the analytical column (Easy-Spray C18 75 µm × 400 mm, 2 µm 
column) using gradient of 97% A (0.1% formic acid) and 3% B (99.9% 
ACN and 0.1% formic acid) to 60% A and 40% B over 120 min at 
a flow rate of 300 nl/min. Data-dependent acquisition consisted 
of a 70,000 resolution full-scan MS scan (AGC set to 106 ions with 
a maximum fill time of 250 ms), and the 10 most abundant peaks 
were selected for MS/MS using a 17,000 resolution scan (AGC set to 
5 × 104 ions with a maximum fill time of 250 ms) with an ion selection 
window of 3 m/z and normalized collision energy of 30. Repeated 
selection of peptides for MS/MS was avoided by a 30-s dynamic ex-
clusion window.
Label-free relative quantification was performed using PEAKS7 
software (Bioinformatics Solutions Inc.) and was searched against 
the UniProt mouse sequence database using an in house Mascot 
server (Matrix Science). Search parameters used were peptide mass 
tolerance	10	ppm;	fragment	mass	tolerance	0.01	Da,	1+,	2+,	3+	ions;	
missed cleavages 1; and instrument types ESI-TRAP. Variable modifi-
cations included in search were oxidation of methionine and cysteine 
residues and N-ethylmaleimide on cysteines. The mass spectrome-
try	proteomic	data	have	been	deposited	 to	 the	ProteomeXchange	
Consortium via the PRIDE (Vizcaino et al., 2016) partner repository 
with	the	dataset	identifier	PXD01009.	Label-free	quantification	data	
were imported into Perseus (Tyanova et al., 2016) software for gen-
eration of heatmaps. Heatmaps represent proteins that significantly 
change	(>2	fold	change	in	abundance	−10logP-value > 20 (equivalent 
to a p-value < .01) and identified with a false discovery rate of < 1%. 
Supporting information including the label free proteomic data has 
been deposited into the Mendeley data set https://doi.org/10.17632 
/gksmy hy89r.1. Pathway analysis of label-free quantitative pro-
teomic data was performed using PathVisio (Kutmon et al., 2015) 
to visualize and highlight altered pathways from detected proteins.
4.6 | Real-time PCR and Western blotting
cDNA synthesis (mRNA) was performed using 500 ng RNA and 
SuperScript II (Thermo Scientific), and cDNA synthesis (microRNA) 
was performed using 100 ng RNA and miRscript RT kit II (Qiagen) 
according to the manufacturer's protocol. qPCR analysis was per-
formed using miScript SYBR Green Master Mix (Qiagen) or sso-
Advanced SYBR Green Master Mix (Bio-Rad) in a 10 µl reaction. 
Expression relative to β2-microblobulin or Rnu-6 and/or Snord-61 
(microRNA) was calculated using delta–delta Ct method. p-value was 
calculated using unpaired Student's t test. The sequences of primers 
used	are	 included	 in	Table	S2.	For	Western	blotting,	homogenized	
protein lysates were diluted using Laemmli buffer and separated on 
12% SDS-PAGE gels. Briefly, 20 µg of protein was loaded, proteins 
were transferred using a semi-dry blotter, and after transfer, mem-
branes were stained with Ponceau S to ensure equivalent loading. 
Membranes were blocked in 3% milk in TBS-T, and following wash-
ing in TBS-T, membranes were incubated with primary antibodies (as 
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above) at a dilution of 1 in 1,000 in blocking buffer. Goat anti-rabbit 
HRP secondary antibody (Cell Signaling) was diluted 1 in 3,000 in 
TBS-T. Thermo super signal west dura was used for chemilumines-
cence detection using a Chemidoc (Bio-Rad), and images were ac-
quired and analyzed using Image Lab 5.0 software (Bio-Rad) and 
normalized using Ponceau S stain.
4.7 | In vitro miRNA target prediction and validation
miR-181 targets were predicted using TargetScan v.6.2 (http://www.
targe	tscan.org/,	release	June	2012)	and	miRWalk	 (http://zmf.umm.
uni-heide lberg.de/apps/zmf/mirwa lk2/) using mouse and human 
searches and broadly conserved microRNA target sites settings. 
3′UTR	regions	with	wild-type	or	mutated	miR-181a	target	site	were	
synthesized using GeneArt service (Thermo Scientific) and cloned 
into	a	GFP	TOPO	vector	(Thermo	Scientific).	Sequences	cloned	are	
listed in Table S3. C2C12 myoblasts were cultured in 96-well plates 
and transfected using Lipofectamine 2000™ (Thermo Scientific) 
with	WT	or	mutant	sensor	(200	ng),	with	100	nM	miR	scrambled	or	
miR-181a mimic (100 nM, GE Healthcare; Soriano-Arroquia, House, 
et al., 2016). Each experiment was carried out using at least two in-
dependent	plasmid	preparations	in	triplicates.	GFP	fluorescence	was	
measured	48	hr	following	transfections	using	FLUOstar	Optima	mi-
croplate reader (BMG Labtech).
4.8 | Quantification and statistical analysis
4.8.1 | Statistical analysis of SDH staining, myofiber 
size, and muscle force
All data are represented as mean ± SEM. Data normality was as-
sessed, and unpaired Student's t test or chi-square test, as indi-
cated in figures, was performed using Prism version 5.01 software 
package	 for	 Windows	 (GraphPad	 Software,	 www.graph	pad.com).	
p-value < .05 was considered as statistically significant, n = 3–6 as 
indicated in figure legends.
4.8.2 | qPCR data
Expression relative to β2-microblobulin or Rnu-6 and/or Snord-61 
(microRNA) was calculated using delta–delta Ct method. p-value was 
calculated using unpaired Student's t test.
4.8.3 | Western blotting
Band intensities were normalized using overall total protein intensity 
from Ponceau S staining. Relative expression was calculated using 
unpaired Student's t test with p-value < .05 considered significant.
4.8.4 | Label-free proteomics
Proteins were quantified using top3 method using PEAKS7 label-
free software, and proteins were considered significantly changed 
with p-value < .01 and >2 fold change.
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